The DOI matches its Crossref record.
Malignancy in systemic lupus erythematosus
Abstract
Objective. To estimate the risk of cancer in patients with systemic lupus erythematosus (SLE). Methods. Patients with SLE (n = 724) have been followed prospectively, for 24 years, at the University of Toronto Lupus Clinic. The diagnosis of cancer was confirmed by histologic or autopsy reports. Standardized rates of cancer and standardized incidence rates (SIR) (ratio of observed‐to‐expected cancers) were used to estimate the risk for cancers. Results. Twenty‐four cancers were identified in 23 SLE patients (3.2%) during 7,233 patient‐years of followup. Compared with the Ontario population, the overall estimated risk for all cancers was not increased in the lupus cohort (SIR 1.08, 95% confidence interval 0.70–1.62). A 4.1‐fold increased risk for hematologic cancers was observed, due mainly to an increased risk of non‐Hodgkin's lymphoma. The risk for cancer was significantly lower in the SLE cohort compared with patients with rheumatoid arthritis (RA) and systemic sclerosis (SSc). Conclusion. SLE is associated with a lower risk of all cancers compared with RA and SSc, but an increased risk for non‐Hodgkin's lymphoma compared with the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cervera, R., Khamashta, M. A., Font, J., Sebastiani, G. D., Gil, A., Lavilla, P., Mejía, J. C., Aydintug, A. O., Chwalinska-Sadowska, H., de Ramón, E., et al. (2003) · Medicine · doi:10.1097/01.md.0000091181.93122.55 · Cited by 1,377
The Risk of Lymphoma Development in Autoimmune Diseases: A Meta-analysis
Zintzaras, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.20.2337 · Cited by 771
Cervera, R., Khamashta, M. A., Font, J., Sebastiani, G. D., Gil, A., Lavilla, P., Aydintug, A. O., Jedryka-Góral, A., Ramón, E. D., Fernández-Nebro, A., et al. (1999) · Medicine · doi:10.1097/00005792-199905000-00003 · Cited by 430
An international cohort study of cancer in systemic lupus erythematosus
Bernatsky, S., Boivin, J. F., Joseph, L., Rajan, R., Zoma, A., Manzi, S., Ginzler, E., Urowitz, M., Gladman, D., Fortin, P. R., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21029 · Cited by 353
Self-citationCancer risk in systemic lupus: An updated international multi-centre cohort study
Bernatsky, S., Ramsey-Goldman, R., Labrecque, J., Joseph, L., Boivin, J.-F., Petri, M., Zoma, A., Manzi, S., Urowitz, M. B., Gladman, D., et al. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.12.009 · Cited by 299
Self-citation
Metadata
- Authors
- Abu‐Shakra, M., Gladman, D. D., & Urowitz, M. B.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1996-06
- Volume
- 39
- Issue
- 6
- Pages
- 1050-1054
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2014008966
- Cited by
- 179
- References
- 0
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Malignancy in systemic lupus erythematosus. https://app.cochat.ai/papers/10.1002/art.1780390625
- The paper
- Abu‐Shakra, M., Gladman, D. D., & Urowitz, M. B. (1996). Malignancy in systemic lupus erythematosus. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780390625
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.